Vimarsana
Biggest News Aggregation in the World

Red Journal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Red Journal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Red Journal Today - Breaking & Trending Today

New Publication Shows DecisionDx®-SCC Identifies High-Risk Squamous Cell Carcinoma Patients Who Are Likely to Benefit from Adjuvant Radiation Therapy and Those Who Can Consider Deferring Treatment Based on Biological Risk of Metastasis - Vimarsana News

New Publication Shows DecisionDx®-SCC Identifies High-Risk Squamous Cell Carcinoma Patients Who Are Likely to Benefit from Adjuvant Radiation Therapy and Those Who Can Consider Deferring Treatment Based on Biological Risk of Metastasis

In the study, patients with DecisionDx-SCC Class 2B test results, predicted to have the highest risk of metastasis by the test, who were treated with adjuvant radiation therapy had 50% higher...

Castle Biosciences Presents New Data at ASTRO 2023 Highlighting Risk-Stratification Performance of DecisionDx®-SCC in Patients with Cutaneous Squamous Cell Carcinoma Eligible for Adjuvant Radiation Therapy - Vimarsana News

Castle Biosciences Presents New Data at ASTRO 2023 Highlighting Risk-Stratification Performance of DecisionDx®-SCC in Patients with Cutaneous Squamous Cell Carcinoma Eligible for Adjuvant Radiation Therapy

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Oct 3, 2023--

Veracyte, Inc. (NASDAQ:VCYT) Q1 2023 Earnings Call Transcript - Vimarsana News

Veracyte, Inc. (NASDAQ:VCYT) Q1 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Veracyte First Quarter 2023 Financial Results Webcast. At this time, all participants are in listen-only mode.

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation | - Vimarsana News

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation |

Radiation is commonly employed in hospitals around the world to treat tumors, typically using gamma ray beams of high energy photons, with a relatively

Veracyte, Inc. (NASDAQ:VCYT) Q4 2022 Earnings Call Transcript - Vimarsana News

Veracyte, Inc. (NASDAQ:VCYT) Q4 2022 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Veracyte Fourth Quarter and Full Year 2022 Financial Results Webcast. At this time, all participants are in a listen-only mode.